Evelo Biosciences Inc (EVLO)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Evelo Biosciences Shareholders Equity (Quarterly): -26.71M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -26.71M |
| June 30, 2023 | -46.13M |
| March 31, 2023 | -27.39M |
| December 31, 2022 | -4.992M |
| September 30, 2022 | 9.334M |
| June 30, 2022 | 35.65M |
| March 31, 2022 | -16.80M |
| December 31, 2021 | 8.667M |
| September 30, 2021 | 33.08M |
| June 30, 2021 | 62.09M |
| March 31, 2021 | 87.84M |
| December 31, 2020 | 30.48M |
| Date | Value |
|---|---|
| September 30, 2020 | 50.43M |
| June 30, 2020 | 69.21M |
| March 31, 2020 | 39.34M |
| December 31, 2019 | 60.20M |
| September 30, 2019 | 80.55M |
| June 30, 2019 | 100.09M |
| March 31, 2019 | 118.88M |
| December 31, 2018 | 136.95M |
| September 30, 2018 | 150.76M |
| June 30, 2018 | 165.05M |
| March 31, 2018 | 101.25M |
| December 31, 2017 | 28.98M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-46.13M
Minimum
Jun 2023
100.09M
Maximum
Jun 2019
30.27M
Average
34.36M
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 229.89M |
| Electromed Inc | 42.54M |
| Xtant Medical Holdings Inc | 47.68M |
| Asensus Surgical Inc | 13.02M |
| Myomo Inc | 10.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.63M |
| Total Liabilities (Quarterly) | 47.33M |